These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26078270)

  • 1. Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming.
    Osmond TL; Farrand KJ; Painter GF; Ruedl C; Petersen TR; Hermans IF
    J Immunol; 2015 Aug; 195(3):821-31. PubMed ID: 26078270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batf3-independent langerin- CX3CR1- CD8α+ splenic DCs represent a precursor for classical cross-presenting CD8α+ DCs.
    Petersen TR; Knight DA; Tang CW; Osmond TL; Hermans IF
    J Leukoc Biol; 2014 Dec; 96(6):1001-10. PubMed ID: 25170118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained in vivo depletion of splenic langerin(+) CD8α(+) dendritic cells is well-tolerated by lang-DTREGFP mice.
    Prendergast KA; Osmond TL; Ochiai S; Hermans IF; Kirman JR
    J Immunol Methods; 2014 Apr; 406():104-9. PubMed ID: 24556588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directly transfected langerin+ dermal dendritic cells potentiate CD8+ T cell responses following intradermal plasmid DNA immunization.
    Elnekave M; Furmanov K; Nudel I; Arizon M; Clausen BE; Hovav AH
    J Immunol; 2010 Sep; 185(6):3463-71. PubMed ID: 20713888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
    Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
    J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.
    Petersen TR; Sika-Paotonu D; Knight DA; Simkins HM; Hermans IF
    PLoS One; 2011 Mar; 6(3):e17657. PubMed ID: 21483862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
    Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
    J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
    Neuenhahn M; Busch DH
    Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.
    Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C
    J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I IFN-induced, NKT cell-mediated negative control of CD8 T cell priming by dendritic cells.
    Bochtler P; Kröger A; Schirmbeck R; Reimann J
    J Immunol; 2008 Aug; 181(3):1633-43. PubMed ID: 18641299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
    Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
    Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI; Camps MGM; de Haas EFE; Ossendorp F
    Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1.
    Yamazaki C; Sugiyama M; Ohta T; Hemmi H; Hamada E; Sasaki I; Fukuda Y; Yano T; Nobuoka M; Hirashima T; Iizuka A; Sato K; Tanaka T; Hoshino K; Kaisho T
    J Immunol; 2013 Jun; 190(12):6071-82. PubMed ID: 23670193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State.
    Széles L; Meissner F; Dunand-Sauthier I; Thelemann C; Hersch M; Singovski S; Haller S; Gobet F; Fuertes Marraco SA; Mann M; Garcin D; Acha-Orbea H; Reith W
    J Immunol; 2015 Aug; 195(3):1025-33. PubMed ID: 26101320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].
    de Brito C; Tomkowiak M; Ghittoni R; Caux C; Leverrier Y; Marvel J
    J Immunol; 2011 Feb; 186(3):1503-11. PubMed ID: 21187449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines.
    Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P
    J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.